References
- Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. New Engl J Med 2007; 357(6)580–587
- George JN, Aster RH. Drug-induced thrombocytopenia: Pathogenesis, evaluation, and management. Hematology American Society of Hematology Education Program 2009; 153–158
- Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 1985; 40(2)111–118
- Montastruc J-L, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M, Bagheri H. Pharmacovigilance for evaluating adverse drug reactions: Value, organization, and methods. Joint Bone Spine 2006; 73(6)629–632
- Purpura thrombopénique immunologique de l'enfant et de l'adulte. Protocole national de diagnostic et de soins [Internet]. Haute Autorité de Santé. 2009 Oct – [cited 1 June 2011]. Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-12/ald_2_pnds_pti_imune_enft_adulte_web.pdf
- George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: A systematic review of published case reports. Ann Int Med 1998; 129(11)886–890
- Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol 2003; 55(1)107–111
- Bertuola F, Morando C, Menniti-Ippolito F, Da Cas R, Capuano A, Perilongo G, Da Dalt L. Association between drug and vaccine use and acute immune thrombocytopenia in childhood: A case-control study in Italy. Drug Saf 2010; 33(1)65–72
- Mantadakis E, Farmaki E, Buchanan GR. Thrombocytopenic purpura after measles-mumps-rubella vaccination: A systematic review of the literature and guidance for management. J Pediatr Hematol/Oncol 2010; 156(4)623–628
- Pugnet G, Ysebaert L, Bagheri H, Montastruc J-L, Laurent G. Immune thrombocytopenic purpura following human papillomavirus vaccination. Vaccine 2009; 27(28)3690
- Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, Shapiro S. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993; 82(9)2714–2718
- ten Berg MJ, Huisman A, Souverein PC, Schobben AF, Egberts AC, van Solinge WW, van den Bemt PM. Drug-induced thrombocytopenia: A population study. Drug Saf 2006; 29(8)713–721
- Rizvi MA, Kojouri K, George JN. Drug-induced thrombocytopenia: An updated systematic review. Ann Int Med 2001; 134(4)346
- Li X, Hunt L, Vesely SK. Drug-induced thrombocytopenia: An updated systematic review. Ann Int Med 2005; 142(6)474–475
- Li X, Swisher KK, Vesely SK, George JN. Drug-induced thrombocytopenia: An updated systematic review, 2006. Drug Saf 2007; 30(2)185–186
- Swisher KK, Li X, Vesely SK, George JN. Drug-induced thrombocytopenia: An updated systematic review, 2008. Drug Saf 2009; 32(1)85–86
- Nguyen L, Reese J, George JN. Drug-induced thrombocytopenia: An updated systematic review, 2010. Drug Saf 2011; 34(5)437–438
- Drug-induced thrombocytopenia. Platelets on the Web. 2010 Oct – [cited 1 June 2011]. Available at: http://www.ouhsc.edu/platelets/
- Visentin GP, Liu CY. Drug-induced thrombocytopenia. Hematol/Oncol Clin North Am 2007; 21(4)685–696, vi
- Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK. Identifying drugs that cause acute thrombocytopenia: An analysis using 3 distinct methods. Blood 2010; 116(12)2127–2133